Review: Antiplatelet drugs: what comes next?
dc.contributor.author | Kei, A. A. | en |
dc.contributor.author | Florentin, M. | en |
dc.contributor.author | Mikhailidis, D. P. | en |
dc.contributor.author | Elisaf, M. S. | en |
dc.contributor.author | Liberopoulos, E. N. | en |
dc.date.accessioned | 2015-11-24T18:53:31Z | |
dc.date.available | 2015-11-24T18:53:31Z | |
dc.identifier.issn | 1938-2723 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18574 | |
dc.rights | Default Licence | - |
dc.subject | Animals | en |
dc.subject | Drug Hypersensitivity/etiology | en |
dc.subject | Humans | en |
dc.subject | Platelet Aggregation Inhibitors/*adverse effects/*classification/*therapeutic use | en |
dc.subject | Thrombosis/drug therapy/mortality | en |
dc.title | Review: Antiplatelet drugs: what comes next? | en |
heal.abstract | Antiplatelet drugs are important components in the management of atherothrombotic vascular disease. However, several limitations restrict the safety and efficacy of current antiplatelet therapy in clinical practice. Interpatient variability and resistance to aspirin and/or clopidogrel has spurred efforts for the development of novel agents. Indeed, several antiplatelet drugs are at various stages of evaluation; those at advanced stage of development are the focus of this review. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1177/1076029610385222 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21078606 | - |
heal.identifier.secondary | http://cat.sagepub.com/content/17/1/9.full.pdf | - |
heal.journalName | Clin Appl Thromb Hemost | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2011 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: